Beyond Price Wars: Using Copay Programs to Drive Adoption
The use of co-pay or coupon cards are typically considered for prescription drugs farther along in their life cycle, when there are either new entrants in the category or when generics of less-expensive biosimilar products become available. A logical thought in the latter case is “all else being equal, a patient and prescriber will prefer the branded product.”
Topic:
Health & Wellness
